Considering that ABD domains location acquired limited effect on proteins bioactivity, we chosen monovalent HA and bivalent HHA HER3 affibody-ABD fusions for following efficacy evaluation
Considering that ABD domains location acquired limited effect on proteins bioactivity, we chosen monovalent HA and bivalent HHA HER3 affibody-ABD fusions for following efficacy evaluation. Open in another window Fig. multivalent HER3 ligands could be useful. Further, this function presents the potential of HER3 affibodies to be used within clinically relevant mixture therapies (e.g., with…